These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33420896)

  • 1. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus.
    Bass ME; Kiser TH; Page RL; McIlvennan CK; Allen LA; Wright G; Shakowski C
    J Thromb Thrombolysis; 2021 Aug; 52(2):517-522. PubMed ID: 33420896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus.
    Willeford A; Zhu W; Stevens C; Thomas IC
    Ann Pharmacother; 2021 Jul; 55(7):839-845. PubMed ID: 33191781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus.
    Herald J; Goitia J; Duan L; Chen A; Lee MS
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):437-444. PubMed ID: 35352321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials.
    Sahlén AO; Jiang H; Lau YH; Cuenza L; Cader FA; Al-Omary M; Surunchupakorn P; Ho KH; Sung J; Lee D; Honda S; Tan Wei Chieh J; Yap J
    J Clin Pharmacol; 2023 Oct; 63(10):1101-1107. PubMed ID: 37139934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.
    Coons EM; Staubes BA; Casey AL; Elagizi-Youssef SA; Mohammed AE; Sharma N; Kline ER
    Ann Pharmacother; 2022 May; 56(5):533-540. PubMed ID: 34470525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and outcomes in patients with left ventricular thrombus - experiences from the Aga Khan University Hospital, Nairobi - Kenya.
    Varwani MH; Shah J; Ngunga M; Jeilan M
    Pan Afr Med J; 2021; 39():212. PubMed ID: 34630824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes.
    Davis KA; Joseph J; Nisly SA
    J Thromb Thrombolysis; 2020 Aug; 50(2):457-461. PubMed ID: 31915998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Extreme Obesity.
    Lorenz MA; Linneman TW
    J Pharm Pract; 2023 Dec; 36(6):1375-1382. PubMed ID: 35938580
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of stroke and other thromboembolic complications after interruption of DOAC therapy compared with warfarin therapy in patients with atrial fibrillation: a retrospective cohort analysis.
    Hellerman Itzhaki M; Greenberg N; Margalit I; Shochat T; Krause I; Goldberg E
    J Investig Med; 2021 Dec; 69(8):1404-1410. PubMed ID: 34353884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.
    Jones DA; Wright P; Alizadeh MA; Fhadil S; Rathod KS; Guttmann O; Knight C; Timmis A; Baumbach A; Wragg A; Mathur A; Antoniou S
    Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):398-404. PubMed ID: 32730627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
    Hosokawa K; Abe K; Funakoshi K; Tamura Y; Nakashima N; Todaka K; Taniguchi Y; Inami T; Adachi S; Tsujino I; Yamashita J; Minatsuki S; Ikeda N; Shimokawahara H; Kawakami T; Ogo T; Hatano M; Ogino H; Fukumoto Y; Tanabe N; Matsubara H; Fukuda K; Tatsumi K; Tsutsui H
    J Thromb Haemost; 2023 Aug; 21(8):2151-2162. PubMed ID: 37044277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡.
    Alcalai R; Butnaru A; Moravsky G; Yagel O; Rashad R; Ibrahimli M; Planer D; Amir O; Elbaz-Greener G; Leibowitz D
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):660-667. PubMed ID: 34279598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulants
    Trongtorsak A; Thangjui S; Kewcharoen J; Polpichai N; Yodsuwan R; Kittipibul V; Friedman HJ; Estrada AQ
    Acta Cardiol; 2021 Nov; 76(9):933-942. PubMed ID: 33393861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses.
    Iskaros O; Marsh K; Papadopoulos J; Manmadhan A; Ahuja T
    J Cardiovasc Pharmacol; 2021 May; 77(5):621-631. PubMed ID: 33560043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
    Iqbal H; Straw S; Craven TP; Stirling K; Wheatcroft SB; Witte KK
    ESC Heart Fail; 2020 Oct; 7(5):2032-2041. PubMed ID: 32583975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min.
    Cline L; Generoso EMG; D'Apice N; Dellinger SK; Tovey A; Clark NP; Nui F; Hui R; Hale SA; Ramsey T; Pontoppidan K; Ekmekdjian H; Fink K; Witt DM; Crowther MA; Delate T
    J Thromb Thrombolysis; 2023 Feb; 55(2):355-364. PubMed ID: 36564588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation.
    Yamaji H; Higashiya S; Murakami T; Hina K; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):246-254. PubMed ID: 31498193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.